Our findings suggested that detecting expression level of TOX may help to predict prognosis and regulating TOX expression in exhausted T cells may provide a potential strategy in maximizing immunotherapy efficacy for lung adenocarcinoma patients. This evidence concerns the gene TOX and lung adenocarcinoma.